To take part in these sessions, register to attend SHA 2020:
Register to SHA2020
Friday 9 October 2020
ESC in Arabia - Managing my patient with Diabetes and (Suspected) Coronary Artery Disease
Chairpersons
Prof. Mohammed Ali Balghith, Prof. Marco Roffi, Prof. Azra Mahmud, Prof. Kadhim Jaffer Sulaiman
| 09:00-10:30 (GMT+1) |
| 09:00-09:05 |
Case presentation: Work up of suspected coronary disease |
Prof. Haleem Shamsan,
Saudi Arabia |
| 09:05-09:30 |
Lifestyle Modification and CAD |
Prof. Meral Kayikcioglu,
Turkey |
| 09:30-09:50 |
Cardiovascular Effects of New Anti-Diabetic Drugs |
Prof. Azra Mahmud, Saudi Arabia |
| 09:50-10:10 |
Multivessel Coronary Artery Disease: Medical Management, PCI or CABG? |
Prof. Marco Roffi,
Switzerland |
| 10:10-10:30 |
Antithrombotic and lipid lowering treatment: should my diabetic patient be treated differently? |
Prof. Naji AlKholaif,
Saudi Arabia |
ESC in Arabia - Chronic Coronary Syndromes
Chairpersons
Dr. Hussam Al Faleh, Dr. Mohammed Al Zubaid, Prof. Meral Kayikcioglu
| 13:30-15:00 (GMT+1) |
| 13:30-13:35 |
Case presentation - patient with low pre-test probability |
Dr. Ihab Soliman,
Saudi Arabia |
| 13:35-14:00 |
Familial Hyperlipidemia: Diagnosis and Management |
Prof. Meral Kayikcioglu,
Turkey |
| 14:00-14:20 |
Work up of suspected chronic coronary syndromes: coronary CT vs. stress imaging |
Dr. Ahmed Aljizeeri,
Saudi Arabia |
| 14:20-14:40 |
Role of revascularization in the aftermath of the ISCHEMIA trial |
Prof. Marco Roffi,
Switzerland |
| 14:40-15:00 |
Lipid levels: the lower the better |
Dr. Abdulaziz Algethami,
Saudi Arabia |
When the heartbeat is too fast or too slow
Chairpersons
Prof. Demosthenes Katritsis, Dr. Ahmed Hersi, Dr. Alawi Alsheikh-Ali
15:00-16:30 (GMT+1)
|
| 15:00-15:05 |
Case presentation: Non-Atrial Fibrillation-Supraventricular Tachycardia |
Dr. Abdulwahab Omer Hussain, Saudi Arabia |
| 15:05-15:35 |
2019 ESC Guidelines on the Management of Patients with Supraventricular Tachycardia |
Prof. Demosthenes Katritsis,
Greece |
| 15:35-16:00 |
Indications for ICD: are the results of the clinical trials still applicable to current practice? |
Dr. Ameen Zagzog,
Saudi Arabia |
| 16:00-16:30 |
2019 EHRA/EAPCI/ACCA Concensus Document on Cardiac Arrhythmias in Acute Coronary Syndromes |
Prof. Demosthenes Katritsis,
Greece |
Saturday 10 October 2020
Latest update on Heart Failure
Chairpersons
Prof. Kadhim Jaffer Sulaiman, Prof. Wael Almahmeed, Prof. Abeer Bakhsh
| 10:30-12:00 (GMT+1) |
| 10:30-10:40 |
Case presentation- HFrEF |
Dr. Maryam AlQaseer,
Saudi Arabia |
| 10:40-11:00 |
SGLT-2 inhibitors: new kids on the heart failure block |
Dr. Waleed Alhabeeb,
Saudi Arabia |
| 11:00-11:20 |
What's new in Pharmacologic Treatment of Acute Heart Failure |
Dr. Kamal AlGhalyini,
Saudi Arabia |
Come and meet us on the virtual ESC Stand!
The European Society of Cardiology is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease. Find out what the ESC can do for you, including:
Connect with the ESC
- Create your My ESC Account – your gateway to the ESC. It’s free and available in a few short clicks!
- Want regular updates on ESC science, tools and congresses and education? Subscribe to our newsletters.
About the European Society of Cardiology
The ESC is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease. It helps more than 100,000 clinicians, scientists, nurses and allied professionals expand the boundaries of cardiovascular medicine.
The ESC publishes scientific journals, an array of textbooks and world renowned ESC Clinical Practice Guidelines. It provides continuing medical education through webinars and classroom courses, and hosts the summit of cardiovascular science each August - ESC Congress - which attracts more than 32,000 heart specialists.
Join our community of cardiologists from more than 150 countries. Become an ESC Professional Member.
Our diversity is our strength
Our mission: To reduce the burden of cardiovascular disease.